Stents, scaffolds and DCB

Latest Stents, scaffolds and DCB content in interventional cardiology - research, practice, and education

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

505 results

Hotline: new coronary devices (DES, BRS, DCB)

14 May 2024 – From EuroPCR 2024

This hotline session provides a comprehensive overview of the latest clinical data on new coronary devices, including bioresorbable scaffolds, drug-coated balloons, and drug-eluting stents. Participants will learn about the outcomes of various randomized trials and registry studies, examining the performance of these innovative technologies in different...

Hotline: New Coronary Devices Unveiled

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment

14 May 2024 – From EuroPCR 2024

Watch this session to gain case-based insights on using DCBs in complex settings. Learn valuable tips and tricks for optimal DCB application, including the best timing and situations for their use. Discover how to effectively implement a hybrid strategy that combines DES and DCB when needed.

Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment

Treatment strategies of calcified lesions

14 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Abstract submissions, explores various treatment strategies for calcified coronary lesions. It includes presentations and discussions on the invasive evaluation of coronary artery compliance modification after intracoronary lithotripsy, a retrospective comparison of rotational atherectomy in NSTE-ACS and stable angina patients, the...

Treatment strategies of calcified lesions

Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI

14 May 2024 – From EuroPCR 2024

This session, with the collaboration of various national societies, focuses on understanding different approaches and techniques for managing challenging situations and complications in patients with ACS and acute heart failure undergoing PCI. It covers the prompt recognition of potential periprocedural complications, various management strategies for PCI...

Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI

Expanding the indications of DCB for complex PCI scenarios

14 May 2024 – From EuroPCR 2024

This session, with the collaboration of various national societies, explores the use of drug-coated balloons (DCBs) in complex PCI scenarios, such as multivessel disease, left main, bifurcations, CTOs, or myocardial infarction. It includes case presentations and discussions on the procedural techniques, patient selection, and lesion preparation...

Expanding the indications of DCB for complex PCI scenarios

Hotline: advances in coronary physiology

14 May 2024 – From EuroPCR 2024

This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...

Hotline: advances in coronary physiology

Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes

14 May 2024 – From EuroPCR 2024

Watch this session to learn how to accurately interpret OCT-visualized dissections for an optimized PCI approach using drug-coated balloons (DCB) or drug-eluting stent (DES), to understand the critical role of sufficient and persistent sirolimus content in the vessel wall after using a sirolimus-coated balloon, to get...

Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes

PCI in patients with diabetes: next generation DES + DCB stent platform in action

14 May 2024 – From EuroPCR 2024

Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...

PCI in patients with diabetes: next generation DES + DCB stent platform in action

DCB PCI in restenosis and de novo lesions

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of drug-coated balloons (DCB) in the management of restenosis and de novo coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of a...

DCB PCI in restenosis and de novo lesions